For a clinicians perspective we talk with Dr. Kevin Yuen about Crinetics’ new acromegaly drug, Palsonify™.

In today’s podcast, Dr. Kevin Yuen, a world-renowned neuroendocrinologist, frequent PWN contributor, and medical director of the Barrow Neurological Institute, discusses Crinetics’ new acromegaly drug Paltusotine (Palsonify™). The drug was recently approved by the Food and Drug Administration. Dr. Yuen explains how this new medication works and provides an excellent clinical perspective on his approach to evaluating new therapies. Read Dr. Kevin Yuen’s PWN articles here.